aripiprazole has been researched along with am 251 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashraf, NS; Cook, D; Costa, MDC; Dharia, RM; Dulchavsky, M; Fischer, S; Gestwicki, JE; Ivanova, MI; Joshi, G; Larsen, MJ; McQuade, TJ; Ouyang, M; Paulson, HL; Schapka, E; Sun, D; Todi, SV; Yang, Y | 1 |
1 other study(ies) available for aripiprazole and am 251
Article | Year |
---|---|
Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.
Topics: Animals; Animals, Genetically Modified; Antipsychotic Agents; Aripiprazole; Ataxin-3; Brain; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Gene Expression Regulation; HEK293 Cells; Humans; Machado-Joseph Disease; Mice; Mutant Proteins; Nerve Tissue Proteins; Organ Culture Techniques; Peptides; Piperidines; Pyrans; Pyrazoles | 2016 |